---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-000020"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2025-01-02T23:59:59+00:00"
generated_at: "2026-05-28T18:43:52.256374+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA announces non-binding discussions to acquire Poolbeg Pharma in all-share deal

## Summary
- Poolbeg shareholders to receive 0.03 HOOKIPA shares per share; expected ~55% ownership of combined entity before planned $30M fundraise.
- Combined group to be Nasdaq-listed with operations in EU, UK, and US; Poolbeg to delist from AIM.
- CVR for HOOKIPA shareholders tied to Gilead milestones (up to $407.5M) and HB-200 proceeds.
- PUSU deadline under UK Takeover Code set for 30 January 2025; no certainty a firm offer will be made.
- Fundraise of up to $30M to extend cash runway through year-end 2026, concurrent with deal completion.

## SEC filing metadata
- accession: 0001104659-25-000020
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2025-01-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465925000020/0001104659-25-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465925000020/tm2432355d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-000020
- JSON: https://secwatch.observer/filing/0001104659-25-000020.json
- Plain text: https://secwatch.observer/filing/0001104659-25-000020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.